Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Elevated Cerebrospinal Fluid Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers.

Dellar ER. et al, (2024), Ann Neurol

The Basis of Cognitive and Behavioral Dysfunction in Amyotrophic Lateral Sclerosis.

Bampton A. et al, (2024), Brain Behav, 14

Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neurons

Dafinca R. et al, (2024), Brain Communications

Personalised penetrance estimation forC9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia

Douglas AGL. et al, (2024), BMJ Neurology Open, 6, e000792 - e000792

Cellular and axonal transport phenotypes due to the C9ORF72 HRE in iPSC motor and sensory neurons.

Scaber J. et al, (2024), Stem Cell Reports

The cortical neurophysiological signature of amyotrophic lateral sclerosis

Trubshaw M. et al, (2024), Brain Communications

Recent insights from human induced pluripotent stem cell models into the role of microglia in amyotrophic lateral sclerosis.

Nikel LM. et al, (2024), Bioessays

An ALS-associated mutation dysregulates microglia-derived extracellular microRNAs in a sex-specific manner.

Christoforidou E. et al, (2024), Dis Model Mech, 17

The ALS-associated TDP-43M337V mutation dysregulates microglia-derived extracellular microRNAs in a sex-specific manner.

Christoforidou E. et al, (2024), Disease models & mechanisms

Venous thromboembolism risk in amyotrophic lateral sclerosis: a hospital record-linkage study.

Goldacre R. et al, (2024), J Neurol Neurosurg Psychiatry

Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.

Young CA. et al, (2024), Amyotroph Lateral Scler Frontotemporal Degener, 1 - 11

Improving the measurement properties of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): deriving a valid measurement total for the calculation of change.

Young CA. et al, (2024), Amyotroph Lateral Scler Frontotemporal Degener, 1 - 10

Mutant GGGGCC RNA prevents YY1 from binding to Fuzzy promoter which stimulates Wnt/β-catenin pathway in C9ALS/FTD.

Chen ZS. et al, (2023), Nat Commun, 14

Data-independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis

Dellar E. et al, (2023), Journal of Neurochemistry

PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice.

Kordala AJ. et al, (2023), EMBO Mol Med

C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9

Vahsen B. et al, (2023), Nature Communications

Primary care blood tests show lipid profile changes in pre-symptomatic amyotrophic lateral sclerosis

Thompson AG. et al, (2023), Brain Communications

Aberrant dynein function promotes TDP-43 aggregation and upregulation of p62 in male mice harboring transgenic human TDP-43.

Christoforidou E. et al, (2023), Amyotroph Lateral Scler Frontotemporal Degener, 1 - 10

Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis

Davies JC. et al, (2023), Brain Communications

Advantages of routine next-generation sequencing over standard genetic testing in the amyotrophic lateral sclerosis clinic.

Scaber J. et al, (2023), Eur J Neurol

Load More

1
2
3
4
5
6
7
...
»